Medicaid Unwinding Linked to Disruption of Chronic Medication Therapy in Youth

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on May 16, 2025.

By Elana Gotkine HealthDay Reporter

FRIDAY, May 16, 2025 -- In young patients, especially young adults, Medicaid unwinding associated with the COVID-19 pandemic disrupted chronic medication therapy, according to a study published online May 2 in Pediatrics.

Noting that Medicaid eligibility determinations paused during the COVID-19 pandemic and resumed in April 2023, Kao-Ping Chua, M.D., Ph.D., from the University of Michigan Medical School in Ann Arbor, and colleagues conducted a difference-in-differences analysis to examine whether this “Medicaid unwinding” disrupted chronic medication therapy in children (0 to 18 years) and young adults (19 to 25 years). Participants were using five chronic medication classes during quarter 1 of 2017 to 2023: attention-deficit/hyperactivity disorder medications, antidepressants, antiepileptics, antipsychotics, and inhaled steroids; sample sizes varied from 226,311 to 4,683,451 person-years.

The researchers found that residence in a state with high Medicaid enrollment loss was associated with a greater reduction in the number of days with active prescriptions for one class and with a greater increase in the risk for having one or more cash-pay prescriptions for three classes among children. Residence in such a state was associated with a greater reduction in the number of days with active prescriptions for two classes and with an elevated risk for having no prescriptions and one or more cash-pay prescriptions for all classes among young adults.

"As policymakers debate whether to enact drastic cuts to Medicaid funding, they should consider the possibility that doing so could similarly disrupt chronic disease therapy for children and young adults, placing them at higher risk for disease exacerbations and absenteeism from school and work," Chua said in a statement.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-05-17 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords